Stockscreener 앱 받기
4.4853
1.70%
-0.0747
Humacyte Inc 주식(HUMA)의 최신 뉴스
DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law - GlobeNewswire
DEADLINE ALERT for WOLF, HUMA, XRX, and ZETA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - GlobeNewswire Inc.
Humacyte (NASDAQ:HUMA) Given Buy Rating at D. Boral Capital - MarketBeat
Humacyte moves to test bioengineered vessel in heart surgery - Investing.com
Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV™ for Coronary Artery Bypass Grafting - The Manila Times
11,105 Shares in Humacyte, Inc. (NASDAQ:HUMA) Acquired by Brookstone Capital Management - Defense World
Humacyte (NASDAQ:HUMA) Stock Price Up 10%Time to Buy? - MarketBeat
Cantor Fitzgerald Boosts Earnings Estimates for Humacyte - Defense World
Humacyte FY2024 EPS Forecast Raised by Cantor Fitzgerald - MarketBeat
Humacyte (NASDAQ:HUMA) Stock Price Down 6.4%What's Next? - MarketBeat
Class Action Filed Against Humacyte, Inc. (HUMA)January 17, 2 - GuruFocus.com
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire
HUMA DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - GlobeNewswire Inc.
HUMA Deadline: Rosen Law Firm Urges Humacyte, Inc. (NASDAQ: HUMA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
Cantor Fitzgerald Forecasts Stronger Earnings for Humacyte - MarketBeat
Humacyte, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsHUMA - PR Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte - Markets Insider
Humacyte, Inc. Class Action: Levi & Korsinsky Reminds Humacyte, - GuruFocus.com
Shareholders that lost money on Humacyte, Inc.(HUMA) should - GlobeNewswire
Humacyte, Inc. (NASDAQ:HUMA) Short Interest Update - MarketBeat
Humacyte, Inc. (HUMA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
HUMA Lawsuit Alert! Class Action Against Humacyte, Inc. - TipRanks
The Gross Law Firm Notifies Shareholders of Humacyte, Inc.(HUMA) of a Class Action Lawsuit and an Upcoming Deadline - Marketscreener.com
Humacyte, Inc. (NASDAQ:HUMA) Receives $13.71 Consensus Target Price from Analysts - MarketBeat
Analysts Set Humacyte, Inc. (NASDAQ:HUMA) Price Target at $13.71 - Defense World
HUMA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Humacyte, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
The Gross Law Firm Reminds Humacyte, Inc. Investors of the - GlobeNewswire
Deadline Soon: Humacyte, Inc. (HUMA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates C - GuruFocus.com
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Humacyte, Inc. of Class Action Lawsuit and Upcoming DeadlinesHUMA - PR Newswire
HUMA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Humacyte, Inc. Investors to Secure Counsel - The Bakersfield Californian
symbol__ Stock Quote Price and Forecast - CNN
Humacyte (NASDAQ:HUMA) Trading Down 6.4%Should You Sell? - MarketBeat
Humacyte (NASDAQ:HUMA) Given “Buy” Rating at D. Boral Capital - Defense World
Contact Levi & Korsinsky by January 17, 2025 Deadline to Join Class Action Against Humacyte, Inc.(HUMA) - Morningstar
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 17, 2025 in Humacyte, Inc. LawsuitHUMA - AccessWire
HUMA Investors Have Opportunity to Lead Humacyte, Inc. Securitie - GuruFocus.com
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
HUMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Humacyte, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte - StreetInsider.com
Investors in Humacyte, Inc. Should Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your RightsHUMA - AccessWire
HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein - GlobeNewswire
HUMACYTE, INC. (NASDAQ: HUMA) DEADLINE ALERT: Bernstein Liebhard - WICZ
Humacyte, Inc. Sued for Securities Law Violations – - GlobeNewswire
Humacyte's (HUMA) "Buy" Rating Reiterated at D. Boral Capital - MarketBeat
Humacyte provides update on commerical launch, pricing of Symvess - TipRanks
Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma - The Manila Times
Humacyte, Inc. (NASDAQ:HUMA) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Humacyte, Inc. (NASDAQ:HUMA) Position Increased by Barclays PLC - Defense World
HUMA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Humacyte, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Shareholders of Humacyte, Inc. Should Contact Levi & Korsinsky Before January 17, 2025 to Discuss Your RightsHUMA - AccessWire
Humacyte, Inc. (NASDAQ:HUMA) Shares Bought by Barclays PLC - MarketBeat
HUMA DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, - GlobeNewswire
HUMA DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before Important January 17 Deadline in Securities Class Action - GlobeNewswire Inc.
HUMA INVESTOR ALERT: Kirby McInerney LLP Reminds Humacyte, - GlobeNewswire
Levi & Korsinsky Reminds Humacyte, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 17, 2025HUMA - AccessWire
Levi & Korsinsky Notifies Shareholders of Humacyte, Inc. (HUMA) of a Class Action Lawsuit and an Upcoming Deadline - AccessWire
Humacyte, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
1.50%
8.49%
자본화:
|
볼륨(24시간):